Services Agreement Neogenix Oncology, Inc. 31.1C PROJECTServices Agreement • July 16th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 16th, 2010 Company Industry
Services Agreement Neogenix Oncology, Inc.Services Agreement • July 16th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 16th, 2010 Company Industry** Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits information subject to the confidentiality request. Omissions are designated with brackets containing two asterisks “[ ** ]”. As part of our confidential treatment request, a complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
Services Agreement Neogenix Oncology, Inc. H16C3 PROJECTServices Agreement • July 16th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 16th, 2010 Company Industry** Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits information subject to the confidentiality request. Omissions are designated with brackets containing two asterisks “[ ** ]”. As part of our confidential treatment request, a complete version of this exhibit has been filed separately with the Securities and Exchange Commission.